Enhanced Recovery After Radical Cystectomy Study
NCT02328417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241
Last updated 2018-02-22
Summary
Prospective non randomized study of two cohorts: usual protocol and the application of accelerated recovery protocol. F/up after discharge, 90 days and thereafter according to protocol of each center. Compliance to be assessed.
Conditions
Interventions
- OTHER
-
Consecutive radical cystectomies
Pre-, intra- and post-operative clinical measures during radical cystectomy clinical process
Sponsors & Collaborators
-
Carlos Llorente
lead OTHER
Principal Investigators
-
Carlos Llorente, MD · Hospital Fundación de Alcorcón
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT06170177 ·Status: RECRUITING
-
Protocol of the Italian Radical Cystectomy Registry
NCT04228198 ·Status: UNKNOWN
-
Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy
NCT03049410 ·Status: COMPLETED ·Phase: NA
-
En Bloc TURBT With Collins Loop vs Conventional TURBT
NCT05027412 ·Status: UNKNOWN ·Phase: NA
-
Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence
NCT05204186 ·Status: UNKNOWN
-
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630
NCT05055050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy
NCT02345473 ·Status: COMPLETED
-
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998 ·Status: RECRUITING
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy
NCT03307200 ·Status: COMPLETED
-
Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy
NCT06294054 ·Status: ACTIVE_NOT_RECRUITING
-
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
NCT02039310 ·Status: COMPLETED
-
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
NCT02145390 ·Status: TERMINATED ·Phase: NA
-
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
NCT06427824 ·Status: RECRUITING ·Phase: NA
-
Pre-operative Immuno-Nutrition in Radical Cystectomy
NCT06355518 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.
NCT04502498 ·Status: UNKNOWN
-
Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer
NCT02252393 ·Status: WITHDRAWN ·Phase: NA
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
NCT02169284 ·Status: TERMINATED ·Phase: PHASE2
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
NCT04939194 ·Status: UNKNOWN ·Phase: PHASE3
-
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
NCT06337305 ·Status: COMPLETED
-
Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
NCT00706641 ·Status: COMPLETED ·Phase: NA